Moritz Mall is a research group leader at the Hector Institute for Translational Brain Research at German Cancer Research Center (DKFZ). His research team employs pluripotent stem cells and cell fate engineering to reconstruct and investigate human development and disease. Their mission is to understand the mechanisms that determine and maintain cell fate, with the goal to treat diseases associated with increased cellular plasticity. Their immediate research focus is to understand the role of cell plasticity in brain disorders and cancer, with a focus on the emerging field of cancer neuroscience. Moritz Mall is the recipient of the  prestigious ERC Starting Grant.
Lab Website: https://www.dkfz.de/en/cell-fate-engineering-and-disease-modeling